Product Images Aripiprazole

This is a chart showing the effect of various drugs on Aripiprazole, with fold change and confidence intervals. The drugs listed include CYP3A4 inhibitors ketoconazole and CYP2D6 inhibitors quinidine, CYP3A inducer carbamazepine, gastric acid blockers famotidine, and other drugs such as valproate, lithium, and lorazepam. The chart shows the relative change in Aripiprazole levels when combined with each drug, compared to a reference level without interacting drugs.*

This text shows a table with different drugs and their effect on Aripiprazole, a medication used to treat mental illnesses such as schizophrenia and bipolar disorder. The drugs are categorized based on their effect on certain enzymes in the body that affect Aripiprazole metabolism. The table also includes a graph that shows the fold change of Dehydro-Aripiprazole, a metabolite of Aripiprazole, in the presence of these drugs. The fold change indicates how much the drug affects the metabolism of Aripiprazole.*

The text seems to be a chart or a table that shows the effect of aripiprazole on other drugs and their fold change and confidence interval. It includes drugs such as dexropmethorphan, varfarin, lamotrigine, lorazepam, venlafaxine, O-desmetnyhenlatasine, and escitalopram. However, the table is not very clear and some characters are missing, making it hard to fully understand the information presented.*

This appears to be a table containing information about the drug Aripiprazole and a placebo. The table shows the proportion of subjects who experienced a relapse, as well as the number of subjects at risk in each group at different time points. The information seems to be related to a clinical trial or study.*

This is a report presenting some efficacy data of Aripiprazole and Placebo, possibly for a clinical trial. The data appears to include the proportion of subjects with relapse and the number of subjects at risk over time. The duration of the study ranged up to 304 days from randomization.*

This is a medication description for Aripiprazole Tablets, USP. Each tablet contains 2 mg of aripiprazole. It is important to follow the usual dosage as indicated in the accompanying prescribing information. The tablets should be stored in tightly closed containers between 15°C to 30°C (59°F to 86°F). The medication should be kept out of reach of children, and the pharmacist should dispense the enclosed Medication Guide to each patient. The product is manufactured by ScieGen Pharmaceuticals, Inc. and comes in a bottle of 30 tablets.*

This is a product description for Aripiprazole Tablets, USP, containing 20mg of aripiprazole per tablet. The usual dosage and prescribing information should be carefully read before use. The tablets should be stored in tightly closed containers at temperatures between 15°C to 30°C (59°F to 86°F). The medication should be kept out of the reach of children. The product comes in a bottle of 1,000 tablets and a medication guide should be provided to each patient. The lot number and expiration date are printed on the bottle. The tablets are manufactured by ScieGen Pharmaceuticals, Inc. located in Hauppauge, NY 11788.*

Each tablet of Aripiprazole, USP contains 30 mg of the medication. The usual dosage and prescribing information should be read before use. The tablets should be stored in tightly closed containers at a temperature range of 15°C to 30°C. The medication should be kept out of reach of children. The pharmacist should dispense the enclosed medication guide to each patient. This medication is only available via prescription. The manufacturer is ScieGen Pharmaceuticals, Inc. located in Hauppauge, NY.*

This is a medication description of Aripiprazole Tablets, containing 30mg of aripiprazole, USP per tablet. The recommended dosage is advised to be read on the accompanying prescribing information. The tablets should be stored in closed containers between 15°C to 30°C. It's important to keep this medication away from children. The medication guide should be provided separately to each patient by the PHARMAGIST. The tablets are manufactured by ScieGen Pharmaceuticals, Inc. and the lot and expiration date are not available in the text.*

This is a medication containing 2mg of aripiprazole, USP that comes in tablets. The usual dosage is indicated in the accompanying prescribing information. It should be stored in a tightly closed container at a temperature between 15°C to 30°C (59°F to 86°F). It is important to keep the medication out of children's reach. The label includes the manufacturer's information and a batch number. The pharmacist is instructed to dispense a medication guide separately to each patient.*

This is a medication called Aripiprazole, USP which comes in the form of tablets. Each tablet contains 5mg of the medication. The usual dosage is mentioned in the accompanying prescription information. The medication must be stored in tightly closed containers at a temperature between 15°C to 30°C (59°F to 86°F). A Medication Guide is enclosed with the tablets which must be given to each patient. The medication should be kept out of the reach of children. The product is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY 11788.*

This is a medication containing 5 mg of aripiprazole per tablet, with the usual dosage information available in the prescribing information. It is recommended to store the tablets in tightly closed containers within a temperature range of 15°C to 30°C. The medication guide should be dispensed to each patient by the pharmacist. This product is manufactured by ScieGen Pharmaceuticals and comes in a bottle of 1,000 tablets.*

Each tablet contains 10 mg of aripiprazole, USP. Usual dosage information is available in the accompanying prescribing information. This medication must be stored in tightly closed containers at 25°C (77°F); excursions are permitted between 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. The medication must be kept out of the reach of children. Aripiprazole Tablets, USP 10 mg contain 30 tablets for a prescription only use. The enclosed medication guide should be dispensed to patients by the pharmacist. The manufacturer of this medication is ScieGen Pharmaceuticals, Inc., located in Hauppauge, NY 11788. The Lot and Exp numbers are not available.*

Each tablet of Aripiprazole, USP contains 10 mg of the active ingredient. The usual dosage should be determined by a qualified healthcare provider and the prescribing information should be carefully read. The tablets should be stored at room temperature and kept in tightly closed containers. The medication should be kept out of the reach of children. The pharmacist should give a Medication Guide to each patient. This particular package contains 1,000 tablets of Aripiprazole manufactured by ScieGen Pharmaceuticals, Inc.*

This is a medication that comes in the form of a tablet with a strength of 15 mg of ariprazole, USP. The recommended dosage and prescribing information can be found with the medication. It should be stored in a tightly closed container within a temperature range of 15°C to 30°C (59°F to 86°F). The medication should be kept out of reach of children and a medication guide should be provided to each patient. The medication is manufactured by ScieGen Pharmaceuticals, Inc. and is only available with a prescription.*

This is a medication description for Aripiprazole tablets USP containing 15 mg of the active ingredient. The usual dosage is provided in the prescribing information. The tablets should be stored in a tightly closed container at room temperature, within the range of 15°C to 30°C. Pharmacists should dispense a medication guide to each patient. This medication is Rx only and should be kept out of reach of children. Lot and expiration information is not available. Manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY.*

Each tablet of Aripiprazole contains 20 mg of the drug. Read the prescribing information for proper dosage. Store the medication in a tightly closed container within the 15°C to 30°C (59°F to 86°F) range. Keep it out of reach of children. Dispense the medication guide to each patient. The tablets were manufactured by ScieGen Pharmaceuticals, Inc. The LOT number is 50228-479-30 and the expiry date is not available.*